Nolvadex or Clomid First for PCT — The Sequencing Question Most Guides Get Wrong
The question of whether to use Nolvadex or Clomid for PCT is asked thousands of times a month across UK bodybuilding communities, and almost every answer frames it as a choice between two interchangeable compounds. They are not interchangeable. Nolvadex and Clomid share a classification as SERMs and a common purpose in post-cycle therapy, but they have different pharmacological structures, different half-lives, different receptor binding profiles and a meaningfully different side effect burden. Understanding those differences is what allows you to decide not just which to use, but in what order, at what dose and under what circumstances — which is the question most PCT guides never actually answer.
This article covers the pharmacological difference between the two compounds at the mechanism level, why Clomid’s internal structure creates a specific problem on longer protocols, what the research shows about their comparative effectiveness, why the combination protocol outperforms either alone, and how to sequence them correctly depending on what your cycle contained.
How Nolvadex and Clomid both work and where they differ
Both Intex Pharma Nolvadex (Tamoxifen Citrate) and Intex Pharma Clomid (Clomiphene Citrate) are Selective Oestrogen Receptor Modulators. Both work by occupying oestrogen receptors at the hypothalamus and pituitary without activating them. The brain interprets this as a low-oestrogen environment and responds by increasing GnRH output, which raises LH and FSH, which signals the testes to resume testosterone production. At this level the two compounds are doing the same job.
The structural differences, however, matter considerably in practice. Tamoxifen is a single compound with a half-life of five to seven days and consistent receptor binding behaviour across its duration of use. Clomiphene is a racemic mixture of two distinct stereoisomers with opposing effects on oestrogen receptors.
A 2024 review published in Pharmaceuticals by Saffati et al. confirms that Clomiphene citrate is composed of 38% zuclomiphene (the cis isomer) and 62% enclomiphene (the trans isomer). Enclomiphene is the active component: a pure oestrogen receptor antagonist at the hypothalamus that drives the LH and FSH increase required for PCT. Zuclomiphene is an oestrogen receptor agonist with a half-life of approximately 30 days. It does not contribute to testosterone recovery. What it does is accumulate in the body over the course of a Clomid protocol and progressively exert estrogenic effects that work against the recovery the enclomiphene component is trying to drive.
This internal pharmacological conflict within Clomid is the reason it produces more side effects than Nolvadex on longer protocols, and it is the reason the sequencing of the two compounds matters.
Why Clomid’s side effect profile is worse than Nolvadex on a standard four-week course
Clomid’s reputation for mood disturbances, visual changes and emotional volatility is well documented in the bodybuilding and clinical literature. The mechanism behind these effects is primarily the zuclomiphene isomer. Because zuclomiphene has a half-life of approximately 30 days, it accumulates with each dose throughout a PCT course. A user taking Clomid at 50mg per day for four weeks is not taking a stable dose of a single compound. They are progressively loading an oestrogen agonist that does not fully clear between doses.
Dr Bruce Gilbert’s andrology practice notes that zuclomiphene’s long-lasting estrogenic activity is the primary contributor to mood lability, breast tenderness and reduced libido reported on Clomid, and that these effects are absent with purified enclomiphene because the problematic isomer is not present. This is consistent with the pharmacology. The longer Clomid is used, the higher the zuclomiphene burden, and the more pronounced the estrogenic side effects become.
Nolvadex does not have this problem. Tamoxifen is a single compound. Its half-life of five to seven days means it reaches a stable plasma concentration within one to two weeks of starting and clears predictably when stopped. There is no accumulating antagonistic isomer working against the recovery process. This is why Nolvadex is consistently described as the cleaner, more tolerable option for PCT.
That said, Clomid has a genuine advantage that Nolvadex does not. The LH response to Clomid is stronger in the early phase of PCT. Research by Vermeulen and Comhaire published in Fertility and Sterility found that Tamoxifen at 20mg per day produced a moderate but significant increase in LH and FSH in healthy males comparable to 150mg of clomiphene, and critically noted that unlike Clomid, Tamoxifen did not blunt the LH response to GnRH on prolonged use. This is a specific and important advantage: Clomid at high doses over time can actually desensitise the pituitary to GnRH stimulation, whereas Tamoxifen does not.
Nolvadex or Clomid first — what the sequencing question is actually asking
Most users asking this question are not really asking whether to use one or the other. They are asking how to structure a protocol that uses both, which is the correct approach for most post-cycle scenarios. The sequencing question has a specific clinical answer that almost no popular PCT guide addresses directly.
The first two weeks of PCT are the most critical. The HPG axis has been suppressed, the testes have been inactive, and the primary goal is to generate the fastest possible restoration of LH and FSH output. This is where Clomid’s early LH-stimulating advantage is most useful and where its zuclomiphene burden is least problematic, because the short duration of the first two weeks does not give zuclomiphene enough time to accumulate to symptomatic levels.
From week three onwards, the goal shifts from rapid stimulation to sustained, stable recovery. The axis is responding, LH and FSH are rising, and the priority is maintaining that recovery without introducing hormonal noise from accumulating estrogenic compounds. This is where Nolvadex alone is more appropriate. It continues to support gonadotropin output, it protects against gynecomastia if oestrogen rises as testosterone recovers, and it does not carry the zuclomiphene accumulation that Clomid would be building toward by this point in the protocol.
The sequencing therefore is not Nolvadex or Clomid first. It is Clomid for weeks one and two to generate the initial LH and FSH stimulus, followed by Nolvadex alone from weeks three and four for stable, clean recovery.
The combination protocol and what the research shows
Running Nolvadex and Clomid simultaneously for the full PCT course is widely practised in UK bodybuilding communities and is often presented as the strongest available PCT option. The pharmacological rationale is sound: Clomid’s stronger initial LH stimulus combined with Nolvadex’s oestrogen receptor blockade and gynecomastia protection covers more bases than either compound alone.
Research published in Translational Andrology and Urology by Saffati et al. confirmed that both Clomiphene and Tamoxifen effectively restore the HPG axis through gonadotropin stimulation, noting that Clomiphene combines enclomiphene’s antagonist effect with zuclomiphene’s agonist activity, while Tamoxifen provides clean, consistent receptor blockade without the competing isomer. Running both at reduced doses captures the LH-stimulating advantage of Clomid without exposing the user to the full zuclomiphene burden of a standard 50mg Clomid protocol.
The practical recommendation that emerges from both the pharmacology and the clinical evidence is Nolvadex 20mg plus Clomid 25mg daily for the full four-week course, or the sequencing approach described above for users who are sensitive to Clomid’s side effects. Either approach outperforms either compound used alone at standard doses for most cycle types.
When to use Nolvadex alone
Nolvadex alone is the appropriate choice for three specific scenarios.
The first is a straightforward testosterone-only cycle of 12 weeks or fewer at moderate doses. The level of suppression from this type of cycle is manageable with Nolvadex alone, and the additional complexity of adding Clomid is not justified when Nolvadex at 40mg tapering to 20mg produces reliable recovery without the zuclomiphene side effect burden.
The second is any user who has demonstrated sensitivity to Clomid on a previous cycle, specifically mood disturbances, visual changes or emotional instability. These are zuclomiphene-mediated effects and they do not improve by reducing the Clomid dose in most cases because the zuclomiphene still accumulates over time. For these users, Nolvadex alone is the cleaner option.
The third is on-cycle gynecomastia prevention rather than PCT. Nolvadex at 10 to 20mg per day blocks oestrogen receptors specifically at breast tissue during an aromatising cycle. Clomid has no meaningful advantage in this application and its side effect profile makes it less appropriate as an on-cycle addition.
When to use Clomid alongside Nolvadex
The Clomid addition is justified in three scenarios where the level of suppression or the compounds involved make a stronger initial gonadotropin stimulus worthwhile.
Long or heavily suppressive cycles, typically 16 weeks or more at high doses, produce deeper HPG axis suppression than a short testosterone cycle. The stronger early LH stimulus from Clomid shortens the time to meaningful gonadotropin recovery in these cases. The zuclomiphene side effect concern applies, but it is outweighed by the recovery benefit when the alternative is an extended period of hypogonadism.
Cycles that included 19-nor compounds such as Nandrolone or Trenbolone require a more aggressive PCT approach because 19-nor steroids suppress the HPG axis more persistently than testosterone alone. Note that these cycles also raise prolactin, and if prolactin is elevated, adding Intex Pharma Cabergoline to the PCT protocol addresses the dopaminergic suppression that neither Nolvadex nor Clomid can reach.
First cycle PCT with uncertainty about individual recovery speed is also a reasonable case for the combination. Using Nolvadex and Clomid together on a first PCT gives you the strongest available foundation for recovery, generates useful bloodwork data on your individual response, and establishes a baseline that informs every future PCT decision.
Practical protocol recommendations
For a standard 12 to 16 week testosterone-based cycle, the cleanest and most evidence-supported protocol is Nolvadex 40mg per day for weeks one and two, then 20mg per day for weeks three and four. Bloodwork four weeks after the last tablet confirms recovery.
For a longer cycle or one containing 19-nor compounds, the combination of Nolvadex 20mg plus Clomid 25mg per day for four weeks, or Clomid 50mg weeks one and two followed by Nolvadex 20mg weeks three and four, gives a stronger recovery stimulus while managing the zuclomiphene accumulation concern through the shorter Clomid exposure window.
HCG, if used, should be completed before either SERM begins. Intex Pharma HCG 5000IU in the two weeks between the last injection and the start of Nolvadex or Clomid primes the testes for the SERM phase. Running HCG simultaneously with a SERM is counterproductive because HCG raises oestrogen, which undermines the oestrogen receptor blockade the SERM depends on.
Both Nolvadex and Clomid are available from the Intex Pharma shop at pharmaceutical grade. Run bloodwork four weeks after the last PCT tablet as the definitive measure of whether recovery is on track.
Available now at Intex Pharma UK
Intex Pharma Nolvadex and Clomid — in stock, same day despatch
Pharmaceutical grade Tamoxifen Citrate and Clomiphene Citrate. Next day UK delivery. 15% off when you pay with Bitcoin using code INTEXBTC15. Ships worldwide.
Buy Intex Pharma Nolvadex — £35.50Buy Intex Pharma Clomid — £36.50Read verified reviews
Frequently asked questions
Should I use Nolvadex or Clomid for PCT?
For most users after a standard testosterone-based cycle, Nolvadex is the cleaner, more tolerable choice and is sufficient as a solo PCT agent. Clomid produces a stronger early LH stimulus but carries a higher side effect burden due to its zuclomiphene isomer accumulating over time. The strongest approach for suppressive or longer cycles is running both at reduced doses: Nolvadex 20mg plus Clomid 25mg daily for four weeks.
Why does Clomid cause more side effects than Nolvadex?
Clomid is a mixture of two isomers. Enclomiphene is the active oestrogen receptor antagonist that drives LH and FSH recovery. Zuclomiphene is an oestrogen receptor agonist with a half-life of approximately 30 days that accumulates throughout the PCT course and progressively exerts estrogenic effects including mood disturbances, visual changes and breast tenderness. Nolvadex is a single compound without a competing isomer and does not produce these effects at standard PCT doses.
Can I run Nolvadex and Clomid at the same time?
Yes. Running Nolvadex 20mg and Clomid 25mg simultaneously for four weeks is a well-established PCT protocol that combines Clomid’s stronger initial LH stimulus with Nolvadex’s consistent receptor blockade and gynecomastia protection. Using both at reduced doses gives the benefits of each compound while limiting the zuclomiphene accumulation that occurs at full Clomid doses.
Should I use HCG before Nolvadex or Clomid?
Yes. HCG should be used in the window between the last injection and the start of SERM therapy, not simultaneously. Running HCG alongside Nolvadex or Clomid is counterproductive because HCG raises oestrogen, which works against the oestrogen receptor blockade both SERMs depend on. The recommended sequence is HCG in weeks one and two after the last injection, then Nolvadex or Clomid starting from week three.
Is Nolvadex better than Clomid for PCT after a Trenbolone or Nandrolone cycle?
Neither compound alone is sufficient for PCT after a 19-nor cycle such as Nandrolone or Trenbolone. These steroids raise prolactin through dopaminergic suppression, which Nolvadex and Clomid do not address. The appropriate protocol after a 19-nor cycle is Nolvadex plus Clomid at reduced doses combined with Cabergoline to manage prolactin. Without addressing prolactin, SERM therapy alone will not produce complete HPG axis recovery in all cases.
How long should PCT last with Nolvadex and Clomid?
Four weeks is appropriate for most cycles of 12 to 16 weeks at standard doses. Six weeks is recommended after longer cycles, heavily stacked cycles or cycles involving multiple suppressive compounds. Bloodwork run four weeks after the last PCT tablet is the definitive way to assess whether the protocol has achieved adequate recovery, not subjective symptoms alone.